R2 v. ISSI
This article was originally published in The Gray Sheet
Intellectual property suit charges Intelligent Systems Software, Inc. with infringing three patents covering the ways in which R2 devices scan, process and display images. PMA-approved by FDA in 1998 for use with film-based screening mammography to assist radiologists in minimizing false readings, R2's ImageChecker received an expanded indication for diagnostic mammograms in 2001. In April, the agency approved R2 CAD technology for use with the GE Senographe full-field digital mammography system. ISSI's MammoReader was PMA-approved for "identifying areas on the original mammogram that may warrant a second review" in January, preceding film digitizer Howtek's acquisition of the firm in February (1"The Gray Sheet" Feb. 25, 2002, p. 8)...
You may also be interested in...
Film digitizer Howtek, Inc. is entering the mammography computer-aided detection market through the acquisition of MammoReader developer Intelligent Systems Software, Inc
As the MHRA prepares to grant approval to the Oxford/AstraZeneca vaccine, Wockhardt is set to supply 100 million doses for the UK government’s own use and its WHO commitments. The company is also in talks with global vaccine developers to manufacture their COVID-19 vaccines for emerging economies